Benzonatate and Full blood count abnormal - a phase IV clinical study of FDA data

Summary:

Full blood count abnormal is reported as a side effect among people who take Benzonatate (benzonatate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ibrance, and have Breast cancer female.

The phase IV clinical study analyzes which people have Full blood count abnormal when taking Benzonatate. It is created by eHealthMe based on reports of 16,665 people who have side effects when taking Benzonatate from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Full blood count abnormal?

Full blood count abnormal is found to be associated with 629 drugs and 378 conditions by eHealthMe. Check the latest studies of Full blood count abnormal.

On Aug, 12, 2026

16,665 people reported to have side effects when taking Benzonatate.
Among them, 15 people (0.09%) have Full blood count abnormal.

Could Benzonatate cause Full blood count abnormal?

Among these 15 people:

How long have people been on Benzonatate when they have Full blood count abnormal? *

What is the gender of people who have Full blood count abnormal when taking Benzonatate? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Full blood count abnormal when taking Benzonatate? *

What are other drugs people take besides Benzonatate? *

What are other side effects people have besides Full blood count abnormal? *

Abdominal Discomfort: 4 people, 26.67%
Nausea (feeling of having an urge to vomit): 4 people, 26.67%
Red Blood Cell Count Decreased: 3 people, 20.00%
Constipation: 3 people, 20.00%
Fatigue (feeling of tiredness): 3 people, 20.00%
Localised Infection (infection at the single location): 3 people, 20.00%
White Blood Cell Count Decreased: 3 people, 20.00%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 2 people, 13.33%
Itching: 2 people, 13.33%
Thrombocytopenia (decrease of platelets in blood): 2 people, 13.33%

What are the existing conditions these people have? *

Breast Cancer Female: 5 people, 33.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 20.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 13.33%
Lymphoma (cancer that begins in immune system cells): 1 person, 6.67%
Essential Thrombocythaemia (chronic blood cancer): 1 person, 6.67%
Anaemia Vitamin B12 Deficiency: 1 person, 6.67%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and have Full blood count abnormal?

- Check whether Full blood count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benzonatate:

Benzonatate (17,274 reports)

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Full blood count abnormal:

Full blood count abnormal (629 drugs)

Browse all the conditions that are associated with Full blood count abnormal:

Full blood count abnormal (378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate (the active ingredients of Benzonatate) and Benzonatate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.